Lonza Group AG (LZAGF) Stock Price, News & Chart

	LZAGF	3759.HK	BIIB	301080.SZ	4583.T	ROIV
Market cap	55.72B	55.85B	37.61B	16.17B	6.73B	27.61B
P/E (TTM)	42.1	27.4	110.2	83.1	—	—
Forward P/E	—	17.2	15.6	—	-2.8	-27.5
Price/book	5.7	2.8	2.0	5.9	4.2	6.5
Dividend yield	0.80%	0.78%	—	0.63%	—	—
1-year change	+23.39%	+19.72%	+62.35%	+57.00%	−35.11%	+85.85%
Today	+0.45%	+3.47%	+2.22%	+1.77%	−2.35%	+6.08%

Market cap

55.72B

55.85B

37.61B

16.17B

6.73B

27.61B

P/E (TTM)

42.1

27.4

110.2

83.1

—

Forward P/E

—

17.2

15.6

—

-2.8

-27.5

Price/book

5.7

2.8

2.0

5.9

4.2

6.5

Dividend yield

0.80%

0.78%

—

0.63%

—

1-year change

+23.39%

+19.72%

+62.35%

+57.00%

−35.11%

+85.85%

Today

+0.45%

+3.47%

+2.22%

+1.77%

−2.35%

+6.08%

Company	Mkt cap	Price	Today
Pharmaron Beijing Co., Ltd.3759.HK · Biotechnology	55.85B	30.400	+3.47%
Biogen Inc.BIIB · Drug Manufacturers - General	37.61B	254.46	+2.22%
Acrobiosystems Co.,Ltd.301080.SZ · Biotechnology	16.17B	96.43	+1.77%
Chiome Bioscience Inc.4583.T · Biotechnology	6.73B	83.00	−2.35%
Roivant Sciences Ltd.ROIV · Biotechnology	27.61B	38.23	+6.08%
Apeloa Pharmaceutical Co.,Ltd000739.SZ · Drug Manufacturers - Specialty & Generic	25.56B	22.06	+2.22%
SanofiSNW.DE · Drug Manufacturers - General	100.81B	84.14	+0.07%
Genmab A/S0MGB.IL · Biotechnology	295.98B	3,696.00	+2.03%

Company	Mkt cap	Price	Today
Natera, Inc.NTRA · Austin, TX Odds	56.36B	391.03	+0.62%
Agilent Technologies, Inc.A · Santa Clara, CA	49.96B	177.17	+0.97%
Shin Nippon Biomedical Laboratories, Ltd.2395.T · Kagoshima, Japan	60.91B	1,463.00	+3.25%
Waters CorporationWAT · Milford, MA	45.91B	467.60	+1.67%
IQVIA Holdings Inc.IQV · Durham, NC	43.47B	263.79	+0.46%
IDEXX Laboratories, Inc.IDXX · Westbrook, ME	55.04B	698.55	+3.94%
Access Bio, Inc.950130.KQ · Somerset, NJ	64.19B	1,825.00	−3.95%
Thyrocare Technologies LimitedTHYROCARE.NS · Navi Mumbai, India	77.95B	489.75	−1.16%

Company	Mkt cap	Price	Today
Becton, Dickinson and CompanyBDX · Medical Instruments & Supplies	56.98B	209.19	+5.56%
UCB SAUNC.F · Biotechnology	54.28B	284.70	+3.11%
ALK-Abelló A/SALK-B.CO · Biotechnology	54.85B	247.20	+1.48%
H. Lundbeck A/S0ND5.IL · Drug Manufacturers - Specialty & Generic	55.31B	55.20	+0.36%
Edwards Lifesciences CorporationEW · Medical Devices	57.28B	99.37	+4.39%
DRTECH Corporation214680.KQ · Medical Devices	52.34B	3,135.00	−0.63%
Humasis Co. Ltd.205470.KQ · Medical Devices	50.10B	2,215.00	−1.12%
Software Service, Inc.3733.T · Health Information Services	52.33B	11,520.00	−0.69%

Company	Mkt cap	Price	Today
Novartis AGNVS · Basel, Switzerland	311.59B	164.98	+3.59%
Roche Holding AGRHO.DE · Basel, Switzerland	348.82B	437.80	0.00%
BeOne Medicines AGONC · Basel, Switzerland	42.98B	377.78	+6.42%
Sandoz Group AGSDZ.SW · Basel, Switzerland	35.84B	82.84	+0.85%
Helvetia Baloise Holding AGHBAN.SW · Basel, Switzerland	22.60B	228.20	+0.80%
Straumann Holding AG0QMV.IL · Basel, Switzerland	17.73B	106.20	−1.12%
Avolta AGAVOL.SW · Basel, Switzerland	7.04B	49.78	−0.04%
HIAG Immobilien Holding AGHIAG.SW · Basel, Switzerland	1.36B	134.20	+0.15%

Company	Mkt cap	Price	Today
Sai Life Sciences LimitedSAILIFE.NS · life sciences · industrial	338.79B	1,594.50	+3.13%
Gufic Biosciences LimitedGUFICBIO.BO · life sciences · industrial	43.65B	435.25	+2.03%
Genscript Biotech Corporation1548.HK · life sciences · industrial	76.81B	33.680	−0.94%
WuXi Biologics (Cayman) Inc.1FW2.F · life sciences · industrial	22.56B	5.48	+1.29%
Gland Pharma LimitedGLAND.NS · life sciences · industrial	518.99B	3,145.20	−0.44%
ScinoPharm Taiwan, Ltd.1789.TW · life sciences · industrial	15.38B	19.45	−2.26%
Orion OyjOFK0.F · life sciences · industrial	14.30B	51.00	+3.24%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.002399.SZ · life sciences · industrial	14.09B	9.60	+1.80%

Company	Mkt cap	Price	Today
Lonza Group AGLZAGY · Correlation 0.53	57.95B	81.44	+2.82%
Merck KGaAMKGAF · Correlation 0.36	72.85B	167.57	+0.07%

Company	Mkt cap	Price	Today
Lonza Group AGLZAGY	57.95B	81.44	+2.82%
Merck KGaAMKGAF	72.85B	167.57	+0.07%
CSL Ltd.CMXHF	66.78B	139.16	0.00%
Daiichi Sankyo Co., Ltd.DSKYF	33.34B	18.30	0.00%
Genmab A/SGNMSF	33.57B	546.00	−3.16%

WRAL News·2d agoNegative

Merck KGaA, Darmstadt, Germany, to Divest CDMO Business to Lonza

Stock quotes, market indicators and the latest market news. Darmstadt, Germany, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Lonza will acquire the business for a mid-triple-digit million-euro amount. The transaction is expected to close in mid-2027,…

MRK

bluewin.ch·2d agoPositive

Lonza Is Significantly Expanding Its Contract Manufacturing Operations in the U.S.

The life sciences company Lonza is significantly expanding its presence in the U.S. It is acquiring five plants in the United States from the German Merck Group. With this transaction, the pharmaceutical supplier is doubling its U.S.…

LTC NVDA SPCX INTC

Seeking Alpha·2d agoPositive

Merck exits U.S. CDMO operations in sale to Lonza

Lonza buys five U.S. CDMO sites from Merck KGaA, expanding bioconjugates and viral vector capabilities. Merck KGaA (MKGAF) has agreed to sell five U.S. contract development and manufacturing (CDMO) sites to Swiss drug manufacturer Lonza…

MRK

@clin_trials·5d agoPositive

Lonza Adds Bioconjugation Suites in Visp to Meet Rising ADC Demand

Lonza's Visp expansion adds 3 multiproduct suites at up to 1200 L plus 500-L single-use capacity to scale commercial ADC production from 2028. "As more ADCs and other bioconjugates advance towards commercialization, customers need…

@nutritionalo·Oct 21Positive

Lonza Capsugel to Feature Organicaps, UC-II, and Capsule Delivery Technologies at SupplySide Global 2026

Nutritional Outlook delivers news for manufacturers of dietary supplements, healthy foods, and nutritional beverages, from research to regulatory updates. Lonza Capsugel will exhibit at SupplySide Global 2026 in Las Vegas, October 28â30,…

SLE

openPR.com·Oct 22

U.S. GMP Plasmid DNA Manufacturing Services Market Is Going to Boom |• Lonza • WuXi AppTec

openPR.com U.S. GMP Plasmid DNA Manufacturing Services Market Is Going to Boom |• Lonza • WuXi AppTec Press release from: WMR Permanent link to this press release: You can edit or delete your press release

manchempharma·Oct 20·2 outletsPositive

Lonza and Onava collaborate to accelerate AI-native biologics discovery with GS Ori-Go Vectors

Lonza, the world's leading contract development and manufacturing organisation (CDMO), and Onava, a biotechnology company building an AI-native platform for biologics discovery, announced today a collaboration to support AI-enabled drug…

ABSI NVS LLY GOOGL

Samsung Biologics Enters ADC Fill-Finish, Taking On Lonza and WuXi

Korea's first economic newspaper, established in 1960. Providing comprehensive coverage of Korean business, finance, technology, and economic news. Samsung Biologics (207940) will launch a drug product (DP) service for antibody-drug…

CHOSUNBIZ·Oct 15Negative

Qurient teams with Lonza to advance dual‑payload ADC platform using CDK7 drug

Deal opens ADC licensing path but hinges on client uptake and clinical proof It is not stopping at developing Mocasiclid as its own new drug, but is moving into a platform business to supply it as the payload (cytotoxic drug) for…

AZN

NBR_magazine·Oct 15Positive

Lonza Capsugel to showcase plant-based Organicaps and advanced capsule technologies at SupplySide Global

Lonza Capsugel has announced it will be showcasing its hard empty capsules and technologies, dosage form expertise, specialised CDMO capabilities and science‑backed health ingredients at this year's SupplySide Global show Based at Booth…

Days on the list

30 d

1 yr

Best

Gainers

—

Losers

—

Most active

—

Most widely held

—

Trending

—

Install

Lonza Group AG

Key statistics

Against its peers

Latest news